LATE-BREAKING ABSTRACT: Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea Year: 2016
Late Breaking Abstract - FACE: Cluster phenotyping predicting outcomes in a prospective multicenter cohort study of chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV). Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019
Late Breaking Abstract - FACE: Prospective multicenter cohort adressing chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV): patient baseline characteristics Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019
Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity Year: 2015
FACE: A prospective multicentre observational cohort study in patients with chronic heart failure (CHF) and central sleep apnoea (CSA) treated with adaptive servoventilation (ASV) Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
FACE: Phenotyping analysis of chronic heart failure (CHF) patients with sleep disordered breathing (SDB) indicated for adaptive servoventilation (ASV): 2-year follow-up results. Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea Year: 2020
LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results – A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA) Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea Year: 2016
Nocturnal oxygen therapy (NOT) versus nasal ventilation with Auto-CS in patients with severe chronic heart failure (CHF) and Cheyne-Stokes respiration (CSR): a long-term study over 2 years Source: Eur Respir J 2002; 20: Suppl. 38, 9s Year: 2002
The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol Source: Eur Respir J 2013; 41: 1017-1022 Year: 2013
LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF) Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016
Long-term efficacy of adaptive servo-ventilation (ASV) in patients with co-existing obstructive sleep apnea (OSAS) and Cheyne-stokes respiration (CSR). A randomised CPAP-controlled trial Source: Annual Congress 2009 - Complex sleep apnoea and adaptive servo ventilation Year: 2009
Predictors of 1-year compliance with adaptive servoventilation in patients with heart failure and sleep disordered breathing: preliminary data from the ADVENT-HF trial Source: Eur Respir J, 53 (2) 1801626; 10.1183/13993003.01626-2018 Year: 2019
Mortality in heart failure patients with nocturnal Cheyne-Stokes respiration receiving adaptive servoventilation (ASV) therapy Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012
Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients – nationwide data from Denmark Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021
COPD and co-existent chronic heart failure (CHF): Response to pulmonary rehabilitation (PR) Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016
Efficacy of auto servo-ventilation (ASV) in patients with co-existing obstructive sleep apnea (OSAS) and Cheyne-Stokes respiration (CSR). A randomized CPAP-controlled trial Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure Year: 2010
Cycle length identifies complex sleep apnea in patients with chronic heart failure - A matched control study Source: International Congress 2016 – Central sleep apnoea and the central regulation of obstructive and central sleep apneoa Year: 2016
LATE-BREAKING ABSTRACT: Heart rate variability (HRV) in patients with severe obstructive sleep apnea syndrome (OSA) and its response to a 3-month continuous positive airway pressure (CPAP) therapy Source: International Congress 2014 – Sleep disordered breathing 4 Year: 2014
Late Breaking Abstract - Effectiveness of multimodal remote patient monitoring at CPAP initiation in Obstructive Sleep Apnea (OSA) with high cardiovascular risk: A randomized trial Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea Year: 2017
Sleep apnea syndrome in patients with stable chronic heart failure: Preliminary results of an Austrian pilot study Source: Annual Congress 2010 - Sleep apnoea: insights from animal models and diagnostic tools Year: 2010